Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 56
Filtrar
1.
mBio ; 12(5): e0203821, 2021 10 26.
Artículo en Inglés | MEDLINE | ID: mdl-34488457

RESUMEN

Urinary tract infection (UTI) is one of the most common infectious conditions affecting people in the United States and around the world. Our knowledge of the host-pathogen interaction during UTI caused by Gram-positive bacterial uropathogens is limited compared to that for Gram-negative pathogens. Here, we investigated whether copper and the primary copper-containing protein, ceruloplasmin, are mobilized to urine during naturally occurring UTI caused by Gram-positive uropathogens in patients. Next, we probed the role of copper resistance in the fitness of methicillin-resistant Staphylococcus aureus (MRSA) during experimental UTI in a murine model. Our findings demonstrate that urinary copper and ceruloplasmin content are elevated during UTI caused by Enterococcus faecalis, S. aureus, S. epidermidis, and S. saprophyticus. MRSA strains successfully colonize the urinary tract of female CBA mice with selective induction of inflammation in the kidneys but not the bladder. MRSA mutants lacking CopL, a copper-binding cell surface lipoprotein, and the ACME genomic region containing copL, exhibit decreased fitness in the mouse urinary tract compared to parental strains. Copper sensitivity assays, cell-associated copper and iron content, and bioavailability of iron during copper stress demonstrate that homeostasis of copper and iron is interlinked in S. aureus. Importantly, relative fitness of the MRSA mutant lacking the ACME region is further decreased in mice that receive supplemental copper compared to the parental strain. In summary, copper is mobilized to the urinary tract during UTI caused by Gram-positive pathogens, and copper resistance is a fitness factor for MRSA during UTI. IMPORTANCE Urinary tract infection (UTI) is an extremely common infectious condition affecting people throughout the world. Increasing antibiotic resistance in pathogens causing UTI threatens our ability to continue to treat patients in the clinics. Better understanding of the host-pathogen interface is critical for development of novel interventional strategies. Here, we sought to elucidate the role of copper in host-Staphylococcus aureus interaction during UTI. Our results reveal that copper is mobilized to the urine as a host response in patients with UTI. Our findings from the murine model of UTI demonstrate that copper resistance is involved in the fitness of methicillin-resistant S. aureus (MRSA) during interaction with the host. We also establish a critical link between adaptation to copper stress and iron homeostasis in S. aureus.


Asunto(s)
Cobre/metabolismo , Staphylococcus aureus Resistente a Meticilina/metabolismo , Infecciones Estafilocócicas/microbiología , Infecciones Urinarias/microbiología , Animales , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Cobre/orina , Femenino , Humanos , Hierro/metabolismo , Hierro/orina , Staphylococcus aureus Resistente a Meticilina/genética , Ratones , Ratones Endogámicos CBA , Infecciones Estafilocócicas/orina , Sistema Urinario/metabolismo , Sistema Urinario/microbiología , Infecciones Urinarias/orina
3.
Adv Wound Care (New Rochelle) ; 9(8): 462-471, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32857020

RESUMEN

Objective: In recent years, reticulated open-cell foam-based closed-incision negative pressure therapy (ROCF-ciNPT) has shown effectiveness in management of various postoperative incisions. These dressings consist of a skin interface layer that absorbs fluid from the skin surface and reduces the potential for microbial colonization within the dressing by means of ionic silver. This study examines the ability of silver to reduce the bioburden within the dressing as well as the localized effect due to potential silver mobility. Approach: Ability of silver to reduce bioburden within the ROCF-ciNPT dressing was assessed using Staphylococcus aureus, Pseudomonas aeruginosa, and Candida spp. Furthermore, silver mobility was assessed using an in vitro skin model to study the zone of inhibition along with released silver quantification. Using a porcine model, diffusion of silver into blood and tissue was studied using emission spectrometry and histology. Results: Microbial growth in the ROCF-ciNPT dressing was significantly reduced (∼2.7-4.9 log reduction) compared to a silver-free negative control. No zone of inhibition was observed for microbial colonies for up to 7 days with minimal localized silver release (<5.5 ppm release). In vivo studies demonstrated no measurable concentration (<0.2 µg/g) of silver in the blood, urine, feces, kidney, and liver tissue biopsy. Innovation: This study provides an important insight into silver concentration and mobility within the ROCF-ciNPT dressing, given emerging concerns associated with potential silver cytotoxicity. Conclusion: These results indicate the concentration of silver (0.019% silver by weight) in the ROCF-ciNPT dressings has been adequate to reduce bioburden within the skin interface layer, while severely limiting the amount of silver leaching out.


Asunto(s)
Candida/efectos de los fármacos , Candidiasis/terapia , Terapia de Presión Negativa para Heridas/métodos , Infecciones por Pseudomonas/terapia , Plata/farmacocinética , Infecciones Estafilocócicas/terapia , Staphylococcus aureus/efectos de los fármacos , Infección de la Herida Quirúrgica/terapia , Herida Quirúrgica/terapia , Animales , Vendajes , Candidiasis/sangre , Candidiasis/microbiología , Candidiasis/orina , Modelos Animales de Enfermedad , Masculino , Infecciones por Pseudomonas/sangre , Infecciones por Pseudomonas/microbiología , Infecciones por Pseudomonas/orina , Pseudomonas aeruginosa/efectos de los fármacos , Plata/sangre , Plata/orina , Infecciones Estafilocócicas/sangre , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/orina , Herida Quirúrgica/sangre , Herida Quirúrgica/orina , Infección de la Herida Quirúrgica/sangre , Infección de la Herida Quirúrgica/microbiología , Infección de la Herida Quirúrgica/orina , Porcinos , Resultado del Tratamiento , Cicatrización de Heridas
4.
BMC Res Notes ; 13(1): 114, 2020 Feb 27.
Artículo en Inglés | MEDLINE | ID: mdl-32103775

RESUMEN

OBJECTIVES: Staphylococcus epidermidis is the primary causative agent of infections associated with indwelling biomaterials. Antibiotic susceptibility patterns, Biofilm formation capability, and screening of responsible genes in biofilm formation procedure in clinical isolates (icaA, icaB, icaC, icaD, sdrG, and atlE) were assigned as the main objectives in this study. The clinical samples were analyzed via standard biochemical assays for identifying different bacteria which were confirmed using the multiplex colony PCR method. Subsequently, biofilm-formation capability, antibiotic susceptibility testing, and the frequency of genes responsible for biofilm formation in the confirmed strains were checked. RESULTS: Out of 183 clinical specimens 54 S. epidermidis isolates were detected by targeting a housekeeping gene (sesc) taking advantage of the PCR procedure. All of the strains were Biofilm forming producers. The in vitro biofilm formation assays determined that 45 (83.33%), 5 (9.26%), 4 (7.41%) were strong, moderate, and weak biofilm former strains respectively. Among the isolated strains, the specific frequencies of the biofilm-forming genes were specified to be (98%) for sdrG, (84%) for atlE, (80%) for icaC, and (70%) for icaD. Cefamandole and Amikacin are the most effective antibiotics in isolated strains. All strains were ascertained to be methicillin and amoxicillin/clavulanic acid resistant.


Asunto(s)
Antibacterianos/farmacología , Proteínas Bacterianas/genética , Biopelículas , Farmacorresistencia Bacteriana/genética , Staphylococcus epidermidis/genética , Proteínas Bacterianas/metabolismo , Genotipo , Humanos , Pruebas de Sensibilidad Microbiana , Fenotipo , Reacción en Cadena de la Polimerasa , Infecciones Relacionadas con Prótesis/microbiología , Infecciones Estafilocócicas/sangre , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/orina , Staphylococcus epidermidis/clasificación , Staphylococcus epidermidis/fisiología
5.
J Infect Public Health ; 13(1): 75-79, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31402312

RESUMEN

PURPOSE: Emergence of multidrug-resistant and methicillin-resistant Staphylococcus aureus (MRSA) infections in HIV patients limit the treatment options and challenge the clinical management of infections. The periodic monitoring of S. aureus infections and its drug resistance profile in HIV patients are of paramount importance in clinical management. MATERIALS AND METHODS: A total of 7204 clinical specimens from HIV patients from 2012 to 2017 were processed for the isolation of S. aureus strains using conventional culture techniques and cultures were identified using standard biochemical test. Antibiotic susceptibility of S. aureus strains was tested by Kirby-Bauer disk diffusion method. RESULTS: A total of 380 (5.3%) S. aureus strains were isolated from HIV patients in the study period. High percentage of S. aureus strains were isolates from urine (69.5%) specimen and 58.4% of S. aureus infections were noted among hospitalized patients. Antibiotic susceptibility profile reveals S. aureus was highly resistant to penicillin (95.2%) followed by cephalexin (84.6%). Methicillin resistance was highly observed in the year 2017 (86%) and the rate of MRSA steadily increasing from 51.8% in 2012 to 86% in 2017. Significant increase of S. aureus infections (35%; p<0.001) and MRSA (76%; p=0.0007) were observed in the year 2016. CONCLUSIONS: This study reports the increasing trends of S. aureus infections and MRSA among HIV patients from Southern India. Multidrug-resistance profile of S. aureus could complicate the selection of proper antibiotic regimens and time cure of HIV patients.


Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple , Infecciones por VIH/microbiología , Infecciones Estafilocócicas/tratamiento farmacológico , Staphylococcus aureus/efectos de los fármacos , Adolescente , Adulto , Anciano , Antibacterianos/uso terapéutico , Pruebas Antimicrobianas de Difusión por Disco , Femenino , Infecciones por VIH/complicaciones , Humanos , India , Masculino , Meticilina/farmacología , Resistencia a la Meticilina , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Persona de Mediana Edad , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/orina , Centros de Atención Terciaria , Adulto Joven
6.
Biosens Bioelectron ; 142: 111570, 2019 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-31401227

RESUMEN

To develop a specific method for the detection of S. aureus, chicken anti-protein A IgY was adopted for specifically capturing S. aureus, depending on the specific recognition of staphylococcal protein A (SPA) by chicken anti-protein A IgY, which can eliminate the interference from protein G-producing Streptococcus. HRP labeled IgG, Fc region of which has a high affinity towards SPA, was paired with IgY for the colorimeter analysis of the system. By optimizing the system, a super-low detection limit of 11 CFU of S. aureus in 100 µL PBS without enrichment, with a linear range from 5.0 × 102 CFU mL-1 to 5.0 × 104 CFU mL-1 was obtained. The entire assay was accomplished in less than 90 min and no cross-reactivity with the other tested bacterial species was observed. Moreover, the developed assay has been applied for the detection of S. aureus in three different types of real samples (sodium chloride injection, apple juice and human urine) with satisfactory results. To the best of our knowledge, it is the first time to report using chicken anti-protein A IgY and any IgG to detect S. aureus based on the dual-recognition mode of SPA. The novel method opened up a way for monitoring S. aureus in food samples with high sensitivity, specificity and simple operation.


Asunto(s)
Técnicas Biosensibles/métodos , Colorimetría/métodos , Inmunoglobulinas/química , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/aislamiento & purificación , Animales , Pollos , Análisis de los Alimentos/métodos , Jugos de Frutas y Vegetales/microbiología , Humanos , Inmunoglobulina G/química , Límite de Detección , Infecciones Estafilocócicas/orina
7.
J Infect Chemother ; 25(6): 437-443, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30782427

RESUMEN

The objective of this study was to explore the optimal dosage regimen of daptomycin and to determine the necessity and validity of a high-dose regimen from the perspectives of PK/PD parameters using Monte Carlo Simulation (MCS) and therapeutic drug monitoring (TDM) in a Japanese clinical setting. The volume of distribution (0.13 ± 0.012 L/kg) in this study was greater than that in healthy volunteers reported in Japan. The range of half-lives was between 8.9 and 34.9 h, which were gradually prolonged as creatinine clearance decreased. In MCS, the cumulative fractions of response (CFR) of the peak/MIC â‰§ 60 and the AUC/MIC â‰§ 666 at the 6 mg/kg q 24 h were 72.0% and 78.8% but at the 10 mg/kg q 24 h, the CFRs improved to both 99%. In TDM with 6 mg/kg q 24 h regimen, the patients who reached the peak and AUC target were 40% (2 out of 5 patients), respectively. The intraindividual variability in daptomycin PK may indicate the necessity of TDM and high-dose regimen, such as over 8 mg/kg, may be needed to ensure the effectiveness especially on Japanese patients with normal renal function.


Asunto(s)
Antibacterianos/farmacología , Daptomicina/farmacología , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Infecciones Estafilocócicas/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Área Bajo la Curva , Creatinina/sangre , Creatinina/metabolismo , Creatinina/orina , Daptomicina/uso terapéutico , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Monitoreo de Drogas/estadística & datos numéricos , Femenino , Semivida , Humanos , Infusiones Intravenosas , Japón , Riñón/efectos de los fármacos , Riñón/fisiología , Masculino , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Método de Montecarlo , Eliminación Renal/efectos de los fármacos , Infecciones Estafilocócicas/sangre , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/orina , Resultado del Tratamiento
8.
Medicina (Kaunas) ; 55(1)2019 Jan 17.
Artículo en Inglés | MEDLINE | ID: mdl-30658484

RESUMEN

Background and objectives: Acute proximal muscle weakness has a broad differential. Infectious myositis is difficult to differentiate clinically from inflammatory myopathy, often causing a delayed diagnosis. Infectious myositis should be thought of as a differential for proximal muscle pain and weakness in the right context. Case Presentation: A 40-year-old male with diabetes presented with exquisite pain and weakness of proximal extremities. He denied trauma, recent travel, new medications, or substance use. He denied prior rheumatologic, thyroid, or musculoskeletal disorders. The urine culture revealed staphylococcal infection with negative blood cultures. Rheumatologic and endocrine workups were negative. Random muscle biopsy was negative for inflammatory infiltrate. MRI of thighs and arms showed innumerable foci of nodular and ring enhancement in the proximal muscle groups. The patient noted improvement after about 10 days of antibiotics with complete resolution at 2 months. Discussion and Conclusion: Bacterial myositis is most often due to Staphylococcus aureus (70%) and affects a single muscle. Multifocal abscesses are rare and strongly suggest transient bacteremia. Our patient most likely had transient initiating staphylococcal bacteremia leading to diffuse myositis and hematogenous urinary tract infection (UTI). A delay in treatment can be life-threatening.


Asunto(s)
Antibacterianos/uso terapéutico , Debilidad Muscular/diagnóstico , Mialgia/diagnóstico , Miositis/diagnóstico , Miositis/tratamiento farmacológico , Infecciones Urinarias/diagnóstico , Infecciones Urinarias/tratamiento farmacológico , Enfermedad Aguda , Adulto , Cuidados Posteriores , Diagnóstico Tardío , Complicaciones de la Diabetes , Diagnóstico Diferencial , Servicio de Urgencia en Hospital , Humanos , Tiempo de Internación , Imagen por Resonancia Magnética , Masculino , Debilidad Muscular/diagnóstico por imagen , Mialgia/diagnóstico por imagen , Miositis/diagnóstico por imagen , Miositis/etiología , Factores de Riesgo , Infecciones Estafilocócicas/orina , Muslo/diagnóstico por imagen , Muslo/fisiopatología , Resultado del Tratamiento , Infecciones Urinarias/orina
9.
Biomarkers ; 24(2): 131-133, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30126316

RESUMEN

CONTEXT: Mupirocin (BactrobanR) is widely prescribed for intra-nasal decolonisation of MRSA for in-patients awaiting surgery or self-medicated for out-patients although adherence for the latter is not monitored. Non-adherence is a widespread pharmaceutical problem but could encourage selection of antibiotic resistance. Mupirocin is only a topical antibiotic because it decomposes in stomach acidity to monic acid A, but this has not previously been exploited as a biomarker for clinical intra-nasal medication. MATERIALS AND METHODS: Urine from three catheterised patients in two London hospitals during and after mupirocin medication, was passed through Waters Oasis cartridges to isolate organic acids. Sensitive LC-MS-MS analysis for monic acid A in methanolic eluate has been developed to identify ∼10 pg. RESULTS: Monic acid A was quantified in all samples from one patient, translating into 6-46 ng from 12 mg mupirocin, assuming 1 L daily urine output. However, no urinary monic acid A was detected for two other patients. DISCUSSION AND CONCLUSIONS: Consistent occurrence of monic acid A in urine of one mupirocin patient shows for the first time that antibiotic distribution across nasal mucous membranes had generally been maintained during medication. In contrast, consistent absence in the two other patients requires wider study in hospital.


Asunto(s)
Biomarcadores/orina , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Infecciones Estafilocócicas/orina , Cromatografía Liquida , Femenino , Humanos , Masculino , Staphylococcus aureus Resistente a Meticilina/patogenicidad , Mupirocina/administración & dosificación , Piranos/orina , Infecciones Estafilocócicas/tratamiento farmacológico , Espectrometría de Masas en Tándem
10.
Future Microbiol ; 13: 1603-1609, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30421630

RESUMEN

AIM: To compare two identification methods for coagulase-negative staphylococci (CoNS) isolated from patients with urinary tract infections, VITEK® 2 and MALDI-TOF VITEK®MS, with genotypic identification by internal transcribed spacer PCR (ITS-PCR). RESULTS: A total of 217 CoNS isolates were studied. Agreement of the VITEK® 2 system with ITS-PCR was 84.8%, with 98% sensitivity and 100% specificity. Thirty-one of the 33 strains incorrectly identified by VITEK® 2 belonged to the species Staphylococcus saprophyticus. MALDI-TOF VITEK®MS showed an excellent correlation with ITS-PCR since it correctly identified all CoNS isolates. CONCLUSION: MALDI-TOF VITEK®MS is more accurate than the automated VITEK® 2 system in identifying CoNS isolated from urinary tract infections to species level, particularly urinary isolates of S. saprophyticus.


Asunto(s)
ADN Bacteriano/genética , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción/métodos , Infecciones Estafilocócicas/microbiología , Staphylococcus saprophyticus/aislamiento & purificación , Infecciones Urinarias/microbiología , Cartilla de ADN/genética , Humanos , Reacción en Cadena de la Polimerasa , Estudios Prospectivos , ARN Ribosómico 16S/genética , ARN Ribosómico 23S/genética , Sensibilidad y Especificidad , Infecciones Estafilocócicas/orina , Staphylococcus saprophyticus/genética , Infecciones Urinarias/orina
11.
Infect Disord Drug Targets ; 18(3): 214-217, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29932037

RESUMEN

BACKGROUND: Because of the unknown situation of antibiotic resistance pattern in the main hospital in Ilam, Iran, we aimed to evaluate the antibiotic resistance pattern of uropathogenic bacteria obtained from referred patients to Imam Khomaini Hospital, Ilam, Iran. So, 114 bacteria were collected during 9-month period and evaluated for their antibiotic resistance patterns. RESULTS: Our results demonstrated that Escherichia coli as the dominant responsible for urinary tract infection. Our results demonstrated that 61.4 % (n = 70) of isolates were positive for E.coli, while lowest prevalence was observed for Staphylococcus aureus and Acinetobacter baumannii. The results also showed that 6.4% (n = 7) were metallo beta lactamase (MBL) producers. Our findings showed only 4 gram positive bacteria were obtained from patients with urinary tract infections including one methicillin resistant S. aureus (MRSA) and 2 vancomycin resistant Enterococcus faecalis (VRE). CONCLUSION: In conclusion, we strongly recommended to perform a perfect study among all hospitals in Iran to evaluate the situation of antibiotic resistance and make a real panel to control this issue.


Asunto(s)
Infecciones por Acinetobacter/microbiología , Acinetobacter baumannii/clasificación , Farmacorresistencia Bacteriana , Infecciones por Escherichia coli/microbiología , Staphylococcus aureus Resistente a Meticilina/clasificación , Infecciones Estafilocócicas/microbiología , Infecciones Urinarias/microbiología , Infecciones por Acinetobacter/tratamiento farmacológico , Infecciones por Acinetobacter/orina , Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/aislamiento & purificación , Antibacterianos/uso terapéutico , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/microbiología , Infección Hospitalaria/orina , Escherichia coli/clasificación , Escherichia coli/efectos de los fármacos , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/tratamiento farmacológico , Infecciones por Escherichia coli/orina , Humanos , Irán , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/orina , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/orina , Enterococos Resistentes a la Vancomicina/clasificación , Enterococos Resistentes a la Vancomicina/efectos de los fármacos , Enterococos Resistentes a la Vancomicina/aislamiento & purificación , beta-Lactamasas/metabolismo
12.
J Glob Antimicrob Resist ; 13: 135-138, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29277727

RESUMEN

OBJECTIVES: High rates of antimicrobial resistance (AMR) are seen throughout Southeast Asia. However, limited AMR data exist for Timor-Leste, which is situated on the south-eastern portion of the Malay Archipelago. The purpose of this study was to identify AMR in bacteria isolated from urine and skin swabs from patients in Dili, the capital of Timor-Leste. METHODS: Urine and skin swabs were collected from symptomatic patients in Timor-Leste and were processed for bacterial culture. Isolates were processed in Australia using a VITEK®2 system for bacterial identification and to determine antimicrobial susceptibility according to Clinical and Laboratory Standards Institute (CLSI) guidelines. RESULTS: A total of 154 urine isolates and 57 skin isolates were analysed. Of the Enterobacteriaceae, 35% were resistant to ceftriaxone with an extended-spectrum ß-lactamase (ESBL)-producing phenotype. Carbapenem resistance was not observed in any of the Gram-negative isolates. Of the Staphylococcus aureus isolates, 11% were of the community-associated methicillin-resistant S. aureus (CA-MRSA) phenotype. CONCLUSIONS: A moderately high proportion of Gram-negative urine isolates in Timor-Leste demonstrate phenotypic ESBL production, and a relatively low proportion of S. aureus isolates were methicillin-resistant. Improved understanding of AMR rates in Timor-Leste can help guide antimicrobial prescribing and inform antimicrobial stewardship strategies.


Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana , Infecciones por Enterobacteriaceae/orina , Enterobacteriaceae/efectos de los fármacos , Enterobacteriaceae/genética , Piel/microbiología , Adolescente , Adulto , Niño , Enterobacteriaceae/aislamiento & purificación , Humanos , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/orina , Timor Oriental , Adulto Joven , beta-Lactamasas/genética
13.
Biosens Bioelectron ; 85: 62-67, 2016 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-27155117

RESUMEN

A tetraphenylethylene based aggregation induced emission (AIE) probe, TPEPyE, bearing a positively charged pyridinium pendant was designed and synthesized. The positively charged TPEPyE can efficiently bind to the negatively charged lipopolysaccharide (LPS) through electrostatic interactions between the two oppositely charged species. As a result, upon the addition of LPS into the PBS solution of TPEPyE, this probe aggregated immediately onto the surface of LPS and resulted over 22-fold of fluorescence enhancement. TPEPyE exhibited good selectivity and high sensitivity toward LPS in PBS buffer solution and the detection limit was calculated to be 370 pM (3.7ng/mL). More notably, TPEPyE also retained good sensitivity and selectivity in artificial urine system (with much higher ionic strength) with the detection limit down to nanomolar. Moreover, this probe can also make a distinction between gram-positive bacteria Staphylococcus aureus (S. aureus) and gram-negative bacteria Escherichia coli (E. coli), making it a promising sensor for clinical monitoring of urinary tract infections.


Asunto(s)
Infecciones por Escherichia coli/orina , Escherichia coli/aislamiento & purificación , Colorantes Fluorescentes/química , Lipopolisacáridos/orina , Infecciones Estafilocócicas/orina , Staphylococcus aureus/aislamiento & purificación , Estilbenos/química , Técnicas Biosensibles/métodos , Humanos , Límite de Detección , Compuestos de Piridinio/química , Espectrometría de Fluorescencia/métodos
14.
Acta Clin Belg ; 70(3): 215-7, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25523318

RESUMEN

Staphylococcus saprophyticus is a well-known cause of uncomplicated urinary tract infections, especially in young and sexually active women. Presence in blood cultures is rare and often attributed to contamination. When bacteremia is significant, it occurs mostly in patients with hematologic malignancies and is predominantly catheter-related. However, we describe a case of significant bacteremia with S. saprophyticus associated with urinary tract infection after extracorporeal shock wave lithotripsy of an ureterolithiasis in an otherwise healthy patient.


Asunto(s)
Ciprofloxacina/administración & dosificación , Litotricia/efectos adversos , Infecciones Estafilocócicas , Staphylococcus saprophyticus , Ureterolitiasis/complicaciones , Infecciones Urinarias , Antibacterianos/administración & dosificación , Bacteriemia/diagnóstico , Bacteriemia/tratamiento farmacológico , Bacteriemia/etiología , Femenino , Humanos , Litotricia/métodos , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Radiografía , Infecciones Estafilocócicas/sangre , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/etiología , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/orina , Staphylococcus saprophyticus/efectos de los fármacos , Staphylococcus saprophyticus/aislamiento & purificación , Resultado del Tratamiento , Ureterolitiasis/diagnóstico por imagen , Ureterolitiasis/fisiopatología , Ureterolitiasis/terapia , Infecciones Urinarias/sangre , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/etiología , Infecciones Urinarias/microbiología , Infecciones Urinarias/orina
15.
Anal Chem ; 86(21): 10653-9, 2014 Nov 04.
Artículo en Inglés | MEDLINE | ID: mdl-25264815

RESUMEN

Preconcentration of pathogens from patient samples represents a great challenge in point-of-care (POC) diagnostics. Here, a low-cost, rapid, and portable agarose-based microfluidic device was developed to concentrate biological fluid from micro- to picoliter volume. The microfluidic concentrator consisted of a glass slide simply covered by an agarose layer with a binary tree-shaped microchannel, in which pathogens could be concentrated at the end of the microchannel due to the capillary effect and the strong water permeability of the agarose gel. The fluorescent Escherichia coli strain OP50 was used to demonstrate the capacity of the agarose-based device. Results showed that 90% recovery efficiency could be achieved with a million-fold volume reduction from 400 µL to 400 pL. For concentration of 1 × 10(3) cells mL(-1) bacteria, approximately ten million-fold enrichment in cell density was realized with volume reduction from 100 µL to 1.6 pL. Urine and blood plasma samples were further tested to validate the developed method. In conjugation with fluorescence immunoassay, we successfully applied the method to the concentration and detection of infectious Staphylococcus aureus in clinics. The agarose-based microfluidic concentrator provided an efficient approach for POC detection of pathogens.


Asunto(s)
Infecciones por Escherichia coli/diagnóstico , Escherichia coli/aislamiento & purificación , Técnicas Analíticas Microfluídicas/instrumentación , Sistemas de Atención de Punto , Infecciones Estafilocócicas/diagnóstico , Staphylococcus aureus/aislamiento & purificación , Diseño de Equipo , Infecciones por Escherichia coli/sangre , Infecciones por Escherichia coli/orina , Técnica del Anticuerpo Fluorescente , Humanos , Masculino , Técnicas Analíticas Microfluídicas/economía , Imagen Óptica , Sistemas de Atención de Punto/economía , Sefarosa/química , Infecciones Estafilocócicas/sangre , Infecciones Estafilocócicas/orina
16.
Br J Biomed Sci ; 71(2): 55-7, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24974679

RESUMEN

Staphylococcus pseudintermedius is a leading aetiologic agent of pyoderma and other body tissue infections in dogs and cats. In recent years, an increased prevalence of methicillin-resistant S. pseudintermedius (MRSP) has been reported. Isolation of MRSP in serious infections poses a major therapeutic challenge as strains are often resistant to all forms of systemic antibiotic used to treat S. pseudintermedius -related infections. This study investigates the occurrence of MRSP from a total of 7183 clinical samples submitted to the authors' laboratories over a 15-month period. Identification was based on standard microbiological identification methods, and by S. pseudintermedius-specific nuc polymerase chain reaction (PCR). Methicillin resistance was confirmed by PBP2a latex agglutination and mecA PCR. Susceptibility against non-beta-lactam antibiotics was carried out using a disc-diffusion method according to Clinical and Laboratory Standards Institute (CLSI) guidelines. In addition, susceptibility to pradofloxacin--a new veterinary fluoroquinolone--was also investigated. SCCmec types were determined by multiplex PCR. Staphylococcus pseudintermedius was isolated from 391 (5%) samples and 20 were confirmed as MRSP from cases of pyoderma, otitis, wound infections, urinary tract infection and mastitis in dogs only. All 20 isolates were resistant to clindamycin and sulphamethoxazole/trimethoprim. Nineteen were resistant to chloramphenicol, enrofloxacin, gentamicin, marbofloxacin and pradofloxacin; additionally, seven isolates were resistant to tetracycline. Fifteen isolates carried SCCmec type II-III, four isolates had type V and one harboured type IV. To date, only a few scientific papers on clinical MRSP strains isolated from the UK have been published, thus the results from this study would provide additional baseline data for further investigations.


Asunto(s)
Antiinfecciosos/farmacología , Enfermedades de los Perros/microbiología , Resistencia a la Meticilina , Infecciones Estafilocócicas/veterinaria , Staphylococcus/efectos de los fármacos , Staphylococcus/aislamiento & purificación , Animales , Técnicas de Tipificación Bacteriana , Perros , Pruebas de Sensibilidad Microbiana , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/orina , Staphylococcus/clasificación , Reino Unido
17.
Georgian Med News ; (218): 44-8, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23787506

RESUMEN

Acute urinary tract infection is considered to be a growing burden in both medical and socio-economic terms. The exact etiologic structure of acute pyelonephritis pathogens, their role and interference is unclear. Thus, we aimed on revealing the species composition and populational levels of microorganisms causing acute inflammation of kidney and perirenal tissues. The study included 145 patients with acute pyelonephritis (mean age 34.15±6.79); 67 (47.2%) male and 78 (53.8%) female. Microbiota was defined in three different portions (samples) of urine taken during on urination. Species were considered as dominant when constancy index was 50.0% or higher, additional - from 25.0% to 50.0% and random species if value less than 25.0%. Received data expectedly correlates with other studies. Conditionally pathogenic Enterobacteriaceae play major role in etiology of acute pyelonephritis. Our study provides further evidence of higher etiologic significance of conditionally pathogenic flora (normal E. coli) over of the traditional pathogenic microorganisms like enteropathogenic Escherichia and Staphylococcus aureus.


Asunto(s)
Pielonefritis/microbiología , Pielonefritis/orina , Infecciones Urinarias/microbiología , Infecciones Urinarias/orina , Adulto , Enterobacteriaceae/aislamiento & purificación , Enterobacteriaceae/patogenicidad , Escherichia coli/aislamiento & purificación , Escherichia coli/patogenicidad , Femenino , Humanos , Masculino , Microbiota , Pielonefritis/patología , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/patología , Infecciones Estafilocócicas/orina , Staphylococcus aureus/aislamiento & purificación , Staphylococcus aureus/patogenicidad , Infecciones Urinarias/patología
18.
Pathol Biol (Paris) ; 61(2): 44-8, 2013 Apr.
Artículo en Francés | MEDLINE | ID: mdl-23498874

RESUMEN

OBJECTIVE: The aim of the study was to determine the distribution and the antibiotic susceptibility of Staphylococcus saprophyticus patterns isolated from urine culture in outpatients (population: 57,000, Elbeuf, Normandie, France). DESIGN: Prospective study from November 2007 to October 2009 in collaboration with three private medical laboratories. Determination of susceptibility to oxacillin by disk diffusion (cefoxitin, and moxalactam), automated method (Vitek BioMérieux 2) and mecA PCR's detection. Determination of the minimum inhibitory concentration by microbroth dilution for other antibiotics. RESULTS: Five thousand and fifty-one bacterial strains isolated, 91 strains of S. saprophyticus (1.8%), 89 in women (2.25%) and two in men (0.18%). S. saprophyticus represented 10.3% and 14.5% of isolates (women respectively aged between 11 and 30; 16 and 20 years); S. saprophyticus is isolated less frequently in winter. mecA PCR detection was positive for two strains. All strains tested were susceptible to ciprofloxacin and furans. Only one strain is resistant to cotrimoxazole. CONCLUSIONS: S. saprophyticus is found mostly in women between 11 to 30 years. Cotrimoxazole (after susceptibility testing) is efficient in case of S. saprophyticus's cystitis. Furans (probabilistic treatment) have to be reevaluated because of the potential for serious adverse effects.


Asunto(s)
Antiinfecciosos/farmacología , Infecciones Estafilocócicas/epidemiología , Infecciones Estafilocócicas/orina , Staphylococcus saprophyticus/efectos de los fármacos , Staphylococcus saprophyticus/aislamiento & purificación , Adolescente , Adulto , Anciano , Niño , Femenino , Francia/epidemiología , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Pacientes Ambulatorios/estadística & datos numéricos , Oxacilina/farmacología , Infecciones Estafilocócicas/microbiología , Staphylococcus saprophyticus/crecimiento & desarrollo , Adulto Joven
19.
APMIS ; 121(1): 72-8, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23030816

RESUMEN

To determine the distribution of urinary tract pathogens with focus on Staphylococcus saprophyticus and analyse the seasonality, antibiotic susceptibility, and gender and age distributions in a large Swedish cohort. S. saprophyticus is considered an important causative agent of urinary tract infection (UTI) in young women, and some earlier studies have reported up to approximately 40% of UTIs in this patient group being caused by S. saprophyticus. We hypothesized that this may be true only in very specific outpatient settings. During the year 2010, 113,720 urine samples were sent for culture to the Karolinska University Hospital, from both clinics in the hospital and from primary care units. Patient age, gender and month of sampling were analysed for S. saprophyticus, Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Species data were obtained for 42,633 (37%) of the urine samples. The most common pathogens were E. coli (57.0%), Enterococcus faecalis (6.5%), K. pneumoniae (5.9%), group B streptococci (5.7%), P. mirabilis (3.0%) and S. saprophyticus (1.8%). The majority of subjects with S. saprophyticus were women 15-29 years of age (63.8%). In this age group, S. saprophyticus constituted 12.5% of all urinary tract pathogens. S. saprophyticus is a common urinary tract pathogen in young women, but its relative importance is low compared with E. coli even in this patient group. For women in other ages and for men, growth of S. saprophyticus is a quite uncommon finding.


Asunto(s)
Infecciones Estafilocócicas/microbiología , Staphylococcus saprophyticus/aislamiento & purificación , Infecciones Urinarias/microbiología , Adolescente , Adulto , Factores de Edad , Antibacterianos/farmacología , Niño , Estudios de Cohortes , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Estaciones del Año , Factores Sexuales , Infecciones Estafilocócicas/epidemiología , Infecciones Estafilocócicas/orina , Staphylococcus saprophyticus/efectos de los fármacos , Suecia/epidemiología , Infecciones Urinarias/epidemiología , Adulto Joven
20.
Foodborne Pathog Dis ; 9(3): 249-57, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22300167

RESUMEN

Staphylococcus spp., including S. aureus, S. intermedius, S. hyicus, S. epidermidis, S. saprophyticus, S. haemolyticus, S. xylosus, and S. carnosus, are major bacterial species associated with food poisoning, and human and veterinary clinics. Traditional methods for the identification of these staphylococci are time-consuming, laborious, or inaccurate. Therefore, rapid and accurate diagnostic methods are needed. In this study, we designed the DNA probes and polymerase chain reaction (PCR) primers for the detection of the aforementioned Staphylococcus species. These primers were proved to be specific for the detection of their corresponding target strains. Furthermore, by using a consensus primer pair, we were able to co-amplify the intergenic region of groES-groEL for these staphylococci. Followed by a chromogenic macroarray system with the specific probes on the plastic chips, these staphylococci in milk products or clinical samples could be simultaneously detected. When the system was used for the inspection of milk or urine samples containing N × 10° target cells per milliliter of the sample, all these staphylococcal species could be identified after an 8-h pre-enrichment step. This system also allowed the adequate diagnosis of bacteremia, since N × 10° target cells per milliliter of the blood samples could be detected after a 12-h pre-enrichment. Compared to the multiplex PCR method, this approach has the additional advantage that it allowed the discrimination of more bacterial strains-even some bacterial strains that may generate PCR products with the same molecular sizes.


Asunto(s)
Proteínas Bacterianas/metabolismo , Chaperoninas/metabolismo , Cartilla de ADN/química , Expresión Génica , Staphylococcus/clasificación , Staphylococcus/aislamiento & purificación , Animales , Bacteriemia/sangre , Bacteriemia/diagnóstico , Bacteriemia/microbiología , Bacteriemia/orina , Proteínas Bacterianas/genética , Chaperonina 10/genética , Chaperonina 10/metabolismo , Chaperonina 60/genética , Chaperonina 60/metabolismo , Chaperoninas/genética , ADN Bacteriano/sangre , ADN Bacteriano/metabolismo , ADN Bacteriano/orina , ADN Intergénico/sangre , ADN Intergénico/metabolismo , ADN Intergénico/orina , Inspección de Alimentos/métodos , Microbiología de Alimentos , Humanos , Leche/microbiología , Tipificación Molecular , Análisis de Secuencia por Matrices de Oligonucleótidos , Reacción en Cadena de la Polimerasa , Serotipificación/métodos , Intoxicación Alimentaria Estafilocócica/sangre , Intoxicación Alimentaria Estafilocócica/diagnóstico , Intoxicación Alimentaria Estafilocócica/microbiología , Intoxicación Alimentaria Estafilocócica/orina , Infecciones Estafilocócicas/sangre , Infecciones Estafilocócicas/diagnóstico , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/orina , Staphylococcus/genética , Staphylococcus/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...